| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |